Cleveland BioLabs (CBLI +2%) moves up today on slightly heavier-than-usual volumes, possibly...

|About: Cleveland BioLabs, Inc. (CBLI)|By:, SA News Editor

Cleveland BioLabs (CBLI +2%) moves up today on slightly heavier-than-usual volumes, possibly getting a boost from North Korea's ramped up nuclear threats and the fact that the company is working on a medical radiation countermeasure, Entolimod. The company also announced late Tuesday that it had received a Notice of Allowance from the FDA for an investigational new drug application for CBL0137.

Subscribe for full text news in your inbox